Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
TNFA elevation
i
Other names:
Tumor Necrosis Factor, Tumor Necrosis Factor Ligand Superfamily Member 2, Cachectin, TNF-Alpha, TNFSF2, TNF-A, TNFA, Tumor Necrosis Factor (TNF Superfamily, Member 2), Tumor Necrosis Factor Ligand 1F, Tumor Necrosis Factor-Alpha, TNF Superfamily, Member 2, TNF Macrophage-Derived, TNF Monocyte-Derived, APC1 Protein, TNLG1F
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
405785
Related biomarkers:
Expression
Others
‹
TNFA-L (7)
PD-L1 elevation + CXCL10 elevation + TNFA elevation (1)
TNFA-H (0)
TNFA-L (7)
PD-L1 elevation + CXCL10 elevation + TNFA elevation (1)
TNFA-H (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
TNFA elevation
Cervical Cancer
TNFA elevation
Cervical Cancer
ipilimumab
Resistant: C3 – Early Trials
ipilimumab
Resistant
:
C3
ipilimumab
Resistant: C3 – Early Trials
ipilimumab
Resistant
:
C3
TNFA elevation
Non Small Cell Lung Cancer
TNFA elevation
Non Small Cell Lung Cancer
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
pembrolizumab
Sensitive: C3 – Early Trials
pembrolizumab
Sensitive
:
C3
TNFA elevation
Non Small Cell Lung Cancer
TNFA elevation
Non Small Cell Lung Cancer
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
nivolumab
Sensitive: C3 – Early Trials
nivolumab
Sensitive
:
C3
TNFA elevation
Small Cell Lung Cancer
TNFA elevation
Small Cell Lung Cancer
ipilimumab
Resistant: C3 – Early Trials
ipilimumab
Resistant
:
C3
ipilimumab
Resistant: C3 – Early Trials
ipilimumab
Resistant
:
C3
TNFA elevation
Lung Cancer
TNFA elevation
Lung Cancer
PD1 inhibitor
Sensitive: C3 – Early Trials
PD1 inhibitor
Sensitive
:
C3
PD1 inhibitor
Sensitive: C3 – Early Trials
PD1 inhibitor
Sensitive
:
C3
TNFA elevation
HER2 Positive Breast Cancer
TNFA elevation
HER2 Positive Breast Cancer
trastuzumab
Sensitive: C3 – Early Trials
trastuzumab
Sensitive
:
C3
trastuzumab
Sensitive: C3 – Early Trials
trastuzumab
Sensitive
:
C3
TNFA elevation
Breast Cancer
TNFA elevation
Breast Cancer
Sensitive: C3 – Early Trials
Sensitive
:
C3
Sensitive: C3 – Early Trials
Sensitive
:
C3
TNFA elevation
Mantle Cell Lymphoma
TNFA elevation
Mantle Cell Lymphoma
umbralisib + ublituximab-xiiy + TG-1701
Sensitive: D – Preclinical
umbralisib + ublituximab-xiiy + TG-1701
Sensitive
:
D
umbralisib + ublituximab-xiiy + TG-1701
Sensitive: D – Preclinical
umbralisib + ublituximab-xiiy + TG-1701
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login